ABVC
ABVC BioPharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.27
-0.10 ▼ -7.30%
🌙 3월 13일 6:31 PM ET (한국 3/14 07:31)
$1.28
+0.01 ▲ +0.79%
| Index | - | P/E | - | EPS (ttm) | -0.38 | Insider Own | 11.37% | Shs Outstand | 0.03B | Perf Week | -5.22% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.02B | Perf Month | -26.59% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | - | Inst Own | 3.36% | Short Float | 1.09% | Perf Quarter | -43.05% |
| Income | -0.01B | P/S | - | EPS this Y | - | Inst Trans | 2.06% | Short Ratio | 4.08 | Perf Half Y | -54.15% |
| Sales | 0.00B | P/B | 2.86 | EPS next 5Y | - | ROA | -55.3% | Short Interest | 0.25M | Perf YTD | -40.38% |
| Book/sh | 0.44 | P/C | 23.24 | EPS past 3/5Y | 57.67% 39.78% | ROE | -128.2% | 52W High | -76.82% ($5.48) | Perf Year | 84.59% |
| Cash/sh | 0.05 | P/FCF | - | Sales past 3/5Y | - | ROIC | -62.21% | 52W Low | 108.2% ($0.61) | Perf 3Y | -78.1% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 21.87% | Gross Margin | - | Volatility(W/M) | 10.68% 8.71% | Perf 5Y | -97.18% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 0.13 | Perf 10Y | -99.91% |
| Dividend Ex-Date | 2013/9/16 | Quick Ratio | 0.41 | EPS Q/Q | -769.09% | Profit Margin | - | RSI (14) | 32.8 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.41 | Sales Q/Q | -100% | SMA20 | -11.74% ($1.44) | Beta | 0.24 | Target Price | $20.2 |
| Payout | - | Debt/Eq | 0.32 | Earnings | - | SMA50 | -28.85% ($1.78) | Rel Volume | 0.88 | Prev Close | $1.37 |
| Employees | 19 | LT Debt/Eq | 0.14 | EPS/Sales Surpr. | - | SMA200 | -48.86% ($2.48) | Avg Volume(3M) | 0.06M | Price | $1.27 |
| IPO | 2004/11/10 | Option/Short | Yes/Yes | Trades | 373 | Volume | 53,454 | Change | -7.3% |
뉴스 로딩 중...